These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8690223)

  • 1. "Kapping" visceral pain in patients with irritable bowel syndrome: does it work?
    Pasricha PJ
    Gastroenterology; 1996 Aug; 111(2):531-3. PubMed ID: 8690223
    [No Abstract]   [Full Text] [Related]  

  • 2. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
    Delvaux M; Louvel D; Lagier E; Scherrer B; Abitbol JL; Frexinos J
    Gastroenterology; 1999 Jan; 116(1):38-45. PubMed ID: 9869600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
    Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
    [No Abstract]   [Full Text] [Related]  

  • 4. [Functional colonic diseases: from physiopathology to pharmacology].
    Bardou M
    Rev Med Interne; 1999 Feb; 20(2):151-7. PubMed ID: 10227093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and clinical experience with fedotozine.
    Delvaux M
    Expert Opin Investig Drugs; 2001 Jan; 10(1):97-110. PubMed ID: 11116283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral analgesia: an emerging concept for managing functional gastrointestinal disease.
    Hasler WL
    Gastroenterology; 1998 Oct; 115(4):1023-4. PubMed ID: 9786728
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs in the management of the irritable bowel syndrome.
    Farthing MJ
    Drugs; 1998 Jul; 56(1):11-21. PubMed ID: 9664195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional intestinal disorders and quality of life].
    Chassany O; Bergmann JF
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C54-62. PubMed ID: 11787380
    [No Abstract]   [Full Text] [Related]  

  • 9. Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors.
    Langlois A; Diop L; Friese N; Pascaud X; Junien JL; Dahl SG; Rivière PJ
    Eur J Pharmacol; 1997 Apr; 324(2-3):211-7. PubMed ID: 9145774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Today's therapy of functional gastrointestinal disorders--does it help?
    Berstad A
    Eur J Surg Suppl; 1998; (583):92-7. PubMed ID: 10027681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study.
    Dapoigny M; Abitbol JL; Fraitag B
    Dig Dis Sci; 1995 Oct; 40(10):2244-9. PubMed ID: 7587797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of alverina citrate and simethicone combination in abdominal pain and discomfort of irritable bowel syndrome].
    Wittmann T; Paradovsky L; Ducrotte P; Bueno L; Andro-Delestrain MC
    Eksp Klin Gastroenterol; 2011; (3):60-7. PubMed ID: 21698811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Old and new physiopathological concepts of irritable bowel syndrome].
    Fioramonti J; Bueno L; Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C34-41. PubMed ID: 11787378
    [No Abstract]   [Full Text] [Related]  

  • 14. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    Grooff B
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):540; author reply 540. PubMed ID: 11925818
    [No Abstract]   [Full Text] [Related]  

  • 15. Why do we hiccup?
    Kahrilas PJ; Shi G
    Gut; 1997 Nov; 41(5):712-3. PubMed ID: 9414986
    [No Abstract]   [Full Text] [Related]  

  • 16. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome.
    Mangel AW; Hahn BA; Heath AT; Northcutt AR; Kong S; Dukes GE; McSorley D
    J Int Med Res; 1998; 26(2):76-81. PubMed ID: 9602985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    de Schryver AM; Samsom M
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):12-7. PubMed ID: 11802330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom expression in pain-predominant functional bowel syndrome: is visceral hyperalgesia the whole truth?
    Shapiro MS; Olden KW
    Am J Gastroenterol; 2000 Apr; 95(4):862-3. PubMed ID: 10763924
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of irritable bowel syndrome.
    Barbara L; Baldi F; Longanesi A
    Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):36-8. PubMed ID: 1756280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome].
    Matsue T; Yamato S; Umeda N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):89-92. PubMed ID: 2273694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.